9 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $1.3B | $59M | 23.6% | 6.6% | 11.3% | 7.9% | $192M | — | $112M |
| 2024 | $1.2B | $54M | 21.7% | 5.8% | 12.9% | 9.0% | $174M | — | $162M |
| 2023 | $1.1B | $62M | 21.9% | 5.7% | 11.2% | 8.2% | $185M | — | $97M |
| 2022 | $787M | $30M | 21.3% | 3.0% | 8.1% | 5.6% | $77M | — | $120M |
| 2021 | $501M | $66M | 22.4% | 6.5% | 26.1% | 18.4% | $24M | — | $91M |
| 2020 | $345M | $46M | 20.3% | 2.4% | 27.8% | 18.3% | $35M | — | $70M |
| 2019 | — | -$9M | — | — | -7.5% | -5.7% | -$4M | — | $80M |
| 2018 | — | $661000 | — | — | -0.7% | 1.6% | $2M | — | $127000 |
| 2017 | — | -$12M | — | — | 12.8% | — | -$10M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $351M | $28M | 25.5% | 11.4% | 6.2% | 3.9% | $44M | — | $153M |
| Mar '26 | $329M | $24M | 25.3% | 10.8% | 5.5% | 3.5% | $40M | — | $132M |
| Dec '25 | $318M | $12M | 24.1% | 4.8% | 2.4% | 1.7% | $49M | — | $112M |
| Sep '25 | $313M | $14M | 23.2% | 6.9% | 2.5% | 1.7% | $46M | — | $134M |
| Jun '25 | $333M | $17M | 23.7% | 7.3% | 3.3% | 2.2% | $50M | — | $133M |
| Mar '25 | $324M | $15M | 23.4% | 7.5% | 3.2% | 2.1% | $47M | — | $109M |
| Dec '24 | $298M | $11M | 21.3% | 5.3% | 2.5% | 1.7% | $50M | — | $162M |
| Sep '24 | $287M | $10M | 20.7% | 4.3% | 2.4% | 1.6% | $43M | — | $91M |
| Jun '24 | $304M | $16M | 22.5% | 6.8% | 3.6% | 2.4% | $56M | — | $95M |
| Mar '24 | $278M | $17M | 22.4% | 6.7% | 3.0% | 2.1% | $25M | — | $115M |
| Dec '23 | $270M | $13M | 21.1% | 5.1% | 2.4% | 1.8% | $37M | — | $97M |
| Sep '23 | $281M | $16M | 22.3% | 6.5% | 3.1% | 2.2% | $53M | — | $158M |
| Jun '23 | $279M | $15M | 21.7% | 5.4% | 3.2% | 2.2% | $75M | — | $171M |
| Mar '23 | $258M | $18M | 22.7% | 5.8% | 4.2% | 2.7% | $20M | — | $155M |
| Dec '22 | $214M | $3M | 20.8% | 1.5% | 0.9% | 0.6% | $51M | — | $120M |
| Sep '22 | $205M | $13M | 22.4% | 5.5% | 3.8% | 2.6% | $20M | — | $73M |
| Jun '22 | $195M | $9M | 22.5% | 4.5% | 2.8% | 1.9% | $19M | — | $55M |
| Mar '22 | $172M | $5M | 19.1% | -0.0% | 1.8% | 1.2% | -$12M | — | $39M |
| Dec '21 | $128M | $15M | 19.7% | -0.1% | 6.0% | 4.2% | $8M | — | $91M |
| Sep '21 | $122M | $17M | 23.3% | 7.4% | 7.5% | 5.0% | $23M | — | $92M |
How the market has priced PGNY against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Progyny, Inc.'s revenue has grown 30.2% per year, and net income grown 4.7% per year. These are computed facts, not advice.
As of FY2025, Progyny, Inc. reported — of total debt against $112M of cash.
In FY2025, gross margin was 23.6%, operating margin 6.6%, and net margin 4.5%.
As of Sep '26, Progyny, Inc. traded at a price-to-earnings ratio of about 34.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.